Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miconazole + fluprednidene cream versus Vobaderm and vehicle in inflamed cutaneous candidiasis
2015-005707-92Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Jun 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of miconazole and fluprednidene in cutaneous candidiasis (3 arms), sponsored by Dermapharm. Primary endpoint: Treatment success at final visit. Started Jun 2016; status: completed.
02
Drugs
miconazolefluprednidene
03
Conditions
cutaneous candidiasis
Beyond the preview
Go deeper on 2015-005707-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005707-92.